Terra Innovatum Global N.V. (NKLR) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 15, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the NKLR SEC filings page.
This page shows Terra Innovatum Global N.V. (NKLR) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 2 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Terra Innovatum’s dominant mechanic is external financing supporting a loss-making operation while negative equity deepens.
From FY2024 to FY2025, operating losses widened to-$33.7M even as operating cash outflow improved to-$10.3M . That cash-versus-accounting divergence suggests reported expenses expanded faster than near-term cash consumption, but the company still required external funding rather than internally generated cash.
The financing pattern overwhelms the operating one: FY2025 financing cash flow was
The balance sheet carries
Financial Health Signals
Terra Innovatum Global N.V. does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
Terra Innovatum Global N.V. reported an operating loss of $33.7M against $1.4M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Terra Innovatum Global N.V.'s EBITDA was -$6.1M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. Against the prior quarter it is up 8.4%.
Terra Innovatum Global N.V. reported -$18.0M in net income in Q2 2026. This represents a decrease of 1475.9% from the same quarter a year earlier. Against the prior quarter it is down 153.9%.
Not reported for Q2 2026.
Cash & Balance Sheet
Terra Innovatum Global N.V. held $91.1M in cash as of Q2 2026; long-term debt is not reported for that period.
Not reported for Q2 2026.
Not reported for Q2 2026.
Margins & Returns
None of these metrics is reported for Q2 2026.
Capital Allocation
Terra Innovatum Global N.V. invested $1.5M in research and development in Q2 2026. This represents an increase of 2544.6% from the same quarter a year earlier. Against the prior quarter it is up 19.6%.
Not reported for Q2 2026.
Not reported for Q2 2026.
NKLR Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| R&D Expenses | $1.5M+2544.6% | $1.2M+3651.5% | N/A | $155K+868.8% | $56K | $33K | N/A | $16K |
| SG&A Expenses | $4.6M+118.5% | $5.4M+281.1% | N/A | $2.1M+106650.0% | $2.1M | $1.4M | N/A | $2K |
| Operating Income | -$6.1M-181.4% | -$6.6M-357.8% | N/A | -$2.3M-12622.2% | -$2.2M | -$1.4M | N/A | -$18K |
| EBITDA | -$6.1M | -$6.6M | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | N/A | N/A | N/A | $537K | N/A | N/A | N/A | N/A |
| Net Income | -$18.0M-1475.9% | -$7.1M-390.7% | N/A | -$3.0M-18768.8% | -$1.1M-5825.0% | -$1.4M | N/A | $16K |
| EPS (Basic) | -$0.16-700.0% | -$0.16-700.0% | N/A | N/A | -$0.02 | -$0.02 | N/A | N/A |
| EPS (Diluted) | -$0.16 | -$0.16 | N/A | N/A | -$0.02 | -$0.02 | N/A | N/A |
| Diluted Shares (Avg) | 110M | 110M | N/A | N/A | 48M | 48M | N/A | N/A |
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, Income Tax.
NKLR Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $98.5M | $101.9M | $106.1M+79106.0% | $3.7M | N/A | N/A | $134K | N/A |
| Current Assets | $97.7M | $101.5M | $106.0M+79029.9% | $3.6M | N/A | N/A | $134K | N/A |
| Cash & Equivalents | $91.1M+2191.8% | $96.7M+219675.0% | $102.9M+149004.3% | $2.2M+15264.3% | $4.0M | $44K | $69K | $14K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Receivable | N/A | N/A | $4K | N/A | N/A | N/A | N/A | N/A |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $214.0M | $200.6M | $199.7M+120216.9% | $8.0M | N/A | N/A | $166K | N/A |
| Current Liabilities | $6.6M | $4.8M | $3.2M+5860.4% | $7.5M | N/A | N/A | $53K | N/A |
| Non-Current Liabilities | $207.4M | $195.8M | $196.6M+173853.1% | $492K | N/A | N/A | $113K | N/A |
| Total Equity | -$115.5M-7443.8% | -$98.7M-6595.5% | -$93.6M-292368.8% | -$4.2M-6709.4% | -$1.5M-8157.9% | -$1.5M | -$32K | $64K |
| Retained Earnings | -$632.4M | -$614.4M | -$607.3M-1641186.5% | -$5.6M | N/A | N/A | -$37K | N/A |
Not reported in any period shown, so not listed: Inventory, Goodwill, Long-Term Debt.
NKLR Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$4.9M-320.0% | -$3.9M-1837.7% | -$6.6M-12138.9% | -$2.3M | -$1.2M | -$199K | -$54K | N/A |
| Depreciation & Amortization | $8K | $6K | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | -$50K | -$328K | -$14K | N/A | N/A | N/A | N/A | N/A |
| Financing Cash Flow | N/A | N/A | $106.5M | $775K | $4.8M | $172K | N/A | N/A |
Not reported in any period shown, so not listed: Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.
NKLR Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Debt-to-Equity, Asset Turnover, FCF Margin.
Note: Shareholder equity is negative (-$93.6M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Where Terra Innovatum Global N.V. Ranks
Frequently Asked Questions
What is Terra Innovatum Global N.V.'s EBITDA?
Terra Innovatum Global N.V. (NKLR) had EBITDA of -$33.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Terra Innovatum Global N.V.'s operating cash flow?
Terra Innovatum Global N.V. (NKLR) recorded an outflow of $10.3M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Terra Innovatum Global N.V.'s total assets?
Terra Innovatum Global N.V. (NKLR) had $106.1M in total assets as of fiscal year 2025, including both current and long-term assets.
How much does Terra Innovatum Global N.V. spend on research and development?
Terra Innovatum Global N.V. (NKLR) invested $1.4M in research and development during fiscal year 2025.
What is Terra Innovatum Global N.V.'s current ratio?
Terra Innovatum Global N.V. (NKLR) had a current ratio of 33.57 as of fiscal year 2025, which is generally considered healthy.
What is Terra Innovatum Global N.V.'s P/E ratio?
Terra Innovatum Global N.V. (NKLR) has no price-to-earnings ratio at the moment: no net income reported. The market capitalization is $507.2M as of Sep 15, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Terra Innovatum Global N.V.'s price-to-sales ratio?
Terra Innovatum Global N.V. (NKLR) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $507.2M as of Sep 15, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does Terra Innovatum Global N.V.'s liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, Terra Innovatum Global N.V. (NKLR) held $102.9M in cash, cash equivalents and investments, and reported an operating cash outflow of $10.3M over that year. Dividing the one by the other, the reported balance equals about 120 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
Why is Terra Innovatum Global N.V.'s debt-to-equity ratio negative or not reported?
Terra Innovatum Global N.V. (NKLR) has negative shareholder equity of -$93.6M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
Can Terra Innovatum Global N.V. cover its interest payments?
Terra Innovatum Global N.V. (NKLR) reported an operating loss of $33.7M against $1.4M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.